These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 24692704

  • 1. Multidrug resistance reversing activity of newly developed phenothiazines on P-glycoprotein (ABCB1)-related resistance of mouse T-lymphoma cells.
    Spengler G, Takács D, Horváth A, Riedl Z, Hajós G, Amaral L, Molnár J.
    Anticancer Res; 2014 Apr; 34(4):1737-41. PubMed ID: 24692704
    [Abstract] [Full Text] [Related]

  • 2. Reversal of ABCB1-related Multidrug Resistance of Colonic Adenocarcinoma Cells by Phenothiazines.
    Takács D, Csonka Á, Horváth Á, Windt T, Gajdács M, Riedl Z, Hajós G, Amaral L, Molnár J, Spengler G.
    Anticancer Res; 2015 Jun; 35(6):3245-51. PubMed ID: 26026084
    [Abstract] [Full Text] [Related]

  • 3. Effect of thioridazine stereoisomers on the drug accumulation of mouse lymphoma and human prostate cancer cell lines in vitro.
    Csonka Á, Spengler G, Martins A, Ocsovszki I, Christensen JB, Hendricks O, Kristiansen JE, Amaral L, Molnar J.
    In Vivo; 2013 Jun; 27(6):815-20. PubMed ID: 24292587
    [Abstract] [Full Text] [Related]

  • 4. Substituted steroidal compounds containing amino and amido groups reverse multidrug resistance of mouse T-lymphoma and two human prostate cancer cell lines in vitro.
    Csonka Á, Hamdoun S, Spengler G, Martins A, Vincze I, Efferth T, Molnár J.
    Anticancer Res; 2015 Apr; 35(4):2105-12. PubMed ID: 25862866
    [Abstract] [Full Text] [Related]

  • 5. [Comparison of the effect of multidrug resistance modifiers on prostate cancer, mouse lymphoma and colon cancer cells].
    Csonka Á.
    Orv Hetil; 2016 Sep; 157(37):1489-95. PubMed ID: 27615200
    [Abstract] [Full Text] [Related]

  • 6. Search for ABCB1 Modulators Among 2-Amine-5-Arylideneimidazolones as a New Perspective to Overcome Cancer Multidrug Resistance.
    Kaczor A, Nové M, Kincses A, Spengler G, Szymańska E, Latacz G, Handzlik J.
    Molecules; 2020 May 11; 25(9):. PubMed ID: 32403277
    [Abstract] [Full Text] [Related]

  • 7. CEP-33779 antagonizes ATP-binding cassette subfamily B member 1 mediated multidrug resistance by inhibiting its transport function.
    Tang SJ, Chen LK, Wang F, Zhang YK, Huang ZC, To KK, Wang XK, Talele TT, Chen ZS, Chen WQ, Fu LW.
    Biochem Pharmacol; 2014 Sep 15; 91(2):144-56. PubMed ID: 25058526
    [Abstract] [Full Text] [Related]

  • 8. Preliminary studies on phenothiazine-mediated reversal of multidrug resistance in mouse lymphoma and COLO 320 cells.
    Pajak B, Molnar J, Engi H, Orzechowski A.
    In Vivo; 2005 Sep 15; 19(6):1101-4. PubMed ID: 16277030
    [Abstract] [Full Text] [Related]

  • 9. Thioridazine induces apoptosis of multidrug-resistant mouse lymphoma cells transfected with the human ABCB1 and inhibits the expression of P-glycoprotein.
    Spengler G, Molnar J, Viveiros M, Amaral L.
    Anticancer Res; 2011 Dec 15; 31(12):4201-5. PubMed ID: 22199281
    [Abstract] [Full Text] [Related]

  • 10. Multidrug resistance reversal in mouse lymphoma cells by heterocyclic compounds.
    Molnár J, Szabo D, Mándi Y, Mucsi I, Fischer J, Varga A, König S, Motohashi N.
    Anticancer Res; 1998 Dec 15; 18(4C):3033-8. PubMed ID: 9713505
    [Abstract] [Full Text] [Related]

  • 11. Epoxylathyrol Derivatives: Modulation of ABCB1-Mediated Multidrug Resistance in Human Colon Adenocarcinoma and Mouse T-Lymphoma Cells.
    Matos AM, Reis M, Duarte N, Spengler G, Molnár J, Ferreira MJ.
    J Nat Prod; 2015 Sep 25; 78(9):2215-28. PubMed ID: 26331763
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of the transport function of membrane proteins by some substituted phenothiazines in E. coli and multidrug resistant tumor cells.
    Molnár J, Hevér A, Fakla I, Fischer J, Ocsovski I, Aszalós A.
    Anticancer Res; 1997 Sep 25; 17(1A):481-6. PubMed ID: 9066699
    [Abstract] [Full Text] [Related]

  • 13. New silicon compounds as resistance modifiers against multidrug-resistant cancer cells.
    Molnar J, Mucsi I, Nacsa J, Hevér A, Gyémánt N, Ugocsai K, Hegyes P, Kiessig S, Gaal D, Lage H, Varga A.
    Anticancer Res; 2004 Sep 25; 24(2B):865-71. PubMed ID: 15161039
    [Abstract] [Full Text] [Related]

  • 14. Phenothiazines and Selenocompounds: A Potential Novel Combination Therapy of Multidrug Resistant Cancer.
    GajdÁcs M, NovÉ M, Csonka Á, Varga B, SanmartÍn C, DomÍnguez-Álvarez E, Spengler G.
    Anticancer Res; 2020 Sep 25; 40(9):4921-4928. PubMed ID: 32878780
    [Abstract] [Full Text] [Related]

  • 15. Benzoxazole-based Zn(II) and Cu(II) Complexes Overcome Multidrug-resistance in Cancer.
    Spengler G, Kincses A, Rácz B, Varga B, Watanabe G, Saijo R, Sekiya H, Tamai E, Maki J, Molnár J, Kawase M.
    Anticancer Res; 2018 Nov 25; 38(11):6181-6187. PubMed ID: 30396935
    [Abstract] [Full Text] [Related]

  • 16. Fluorinated β-Diketo Phosphorus Ylides Are Novel Inhibitors of the ABCB1 Efflux Pump of Cancer Cells.
    Spengler G, Ocsovszki I, Tönki ÁS, Saijo R, Watanabe G, Kawase M, Molnár J.
    Anticancer Res; 2015 Nov 25; 35(11):5915-9. PubMed ID: 26504015
    [Abstract] [Full Text] [Related]

  • 17. Differential effect of phenothiazines on MRP1 and P-glycoprotein activity.
    Wesołowska O, Molnar J, Ocsovszki I, Michalak K.
    In Vivo; 2009 Nov 25; 23(6):943-7. PubMed ID: 20023237
    [Abstract] [Full Text] [Related]

  • 18. Synthesis and biochemical characterization of new phenothiazines and related drugs as MDR reversal agents.
    Schmidt M, Teitge M, Castillo ME, Brandt T, Dobner B, Langner A.
    Arch Pharm (Weinheim); 2008 Oct 25; 341(10):624-38. PubMed ID: 18816589
    [Abstract] [Full Text] [Related]

  • 19. In Vitro Evaluation of the Multidrug Resistance Reversing Activity of Novel Imidazo[4,5-b]pyridine Derivatives.
    Bourichi S, Misbahi H, Rodi YK, Chahdi FO, Essassi EM, Szabó S, Szalontai B, Gajdács M, Molnár J, Spengler G.
    Anticancer Res; 2018 Jul 25; 38(7):3999-4003. PubMed ID: 29970523
    [Abstract] [Full Text] [Related]

  • 20. Discovery of phenylselenoether-hydantoin hybrids as ABCB1 efflux pump modulating agents with cytotoxic and antiproliferative actions in resistant T-lymphoma.
    Ali W, Spengler G, Kincses A, Nové M, Battistelli C, Latacz G, Starek M, Dąbrowska M, Honkisz-Orzechowska E, Romanelli A, Rasile MM, Szymańska E, Jacob C, Zwergel C, Handzlik J.
    Eur J Med Chem; 2020 Aug 15; 200():112435. PubMed ID: 32505850
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.